Addition of azithromycin appeared to be associated with an increased risk of 30 - day cardiovascular mortality ( calibrated HR 2 ยท 19 [ 95 % CI Interpretation Hydroxychloroquine treatment appears to have no increased risk in the short term among patients with rheumatoid arthritis , but in the long term it appears to be associated with excess cardiovascular mortality .